Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 472

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.

Drug effects on salivary glands: dry mouth

Open access
Scully CBE, C·2003·Oral Diseases

Abstract

Objective: To identify drugs associated with the complaint of dry mouth. Materials and Methods: MEDLINE was searched for papers 1980–2002 using keywords, oral, mouth, salivary, drugs, dry mouth and xerostomia, and relevant secondary references were hand‐searched. Results: Evidence was forthcoming for a number of xerogenic drugs, especially antimuscarinic agents, some sympathomimetic agents, and agents affecting serotonin and noradrenaline uptake, as well as a miscellany of other drugs such as appetite suppressants, protease inhibitors and cytokines. Conclusion: Dry mouth has a variety of possible causes but drugs – especially those with anticholinergic activity against the M3 muscarinic receptor – are the most common cause of reduced salivation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1034/j.1601-0825.2003.03967.x

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 99 references

Research works printed but not linked: 51

  1. 10.1002/14651858.CD003534 · doi:10.1002/14651858.cd003534
  2. 10.1111/j.1741-2358.1989.tb00398.x · doi:10.1111/j.1741-2358.1989.tb00398.x
  3. 10.1007/s002280050298 · doi:10.1007/s002280050298
  4. 10.1111/j.1753-4887.1997.tb01562.x · doi:10.1111/j.1753-4887.1997.tb01562.x
  5. 10.1007/s005200050261 · doi:10.1007/s005200050261
  6. 10.1016/S0039-6109(05)70405-9 · doi:10.1016/s0039-6109(05)70405-9
  7. 10.1159/000055306 · doi:10.1159/000055306
  8. 10.2165/00002512-200118040-00005 · doi:10.2165/00002512-200118040-00005
  9. 10.2165/00002512-200016020-00008 · doi:10.2165/00002512-200016020-00008
  10. 10.1097/00002030-199710001-00007 · doi:10.1097/00002030-199710001-00007
  11. 10.1177/030006057900700405 · doi:10.1177/030006057900700405
  12. 10.1016/S0885-3924(01)00318-9 · doi:10.1016/s0885-3924(01)00318-9
  13. 10.1111/j.1754-4505.1990.tb00785.x · doi:10.1111/j.1754-4505.1990.tb00785.x
  14. 10.1016/0140-6736(92)92330-I · doi:10.1016/0140-6736(92)92330-i
  15. Freye E, 2001, Dose‐related effects of controlled release dihydrocodeine on oro‐cecal transit and pupillary light reflex. A study in human volunteers, Arzneimittelforschung, 51, 60
  16. 10.1517/14656566.3.7.827 · doi:10.1517/14656566.3.7.827
  17. Goodman GE, 1983, Phase I trial of retinol in cancer patients, J Clin Oncol, 1, 394, 10.1200/JCO.1983.1.6.394 · doi:10.1200/jco.1983.1.6.394
  18. 10.1038/sj.bdj.4809668 · doi:10.1038/sj.bdj.4809668
  19. 10.1067/mob.2001.116371 · doi:10.1067/mob.2001.116371
  20. 10.1002/14651858.CD003781 · doi:10.1002/14651858.cd003781
  21. Howe AM, 1995, Methamphetamine and childhood and adolescent caries, Aust Dent J, 40, 340
  22. 10.1016/S0301-2115(00)00561-3 · doi:10.1016/s0301-2115(00)00561-3
  23. 10.1097/00042737-200108000-00007 · doi:10.1097/00042737-200108000-00007
  24. 10.1254/fpj.105.295 · doi:10.1254/fpj.105.295
  25. 10.1016/0964-1955(92)90040-8 · doi:10.1016/0964-1955(92)90040-8
  26. 10.1016/S0009-9236(01)78384-1 · doi:10.1016/s0009-9236(01)78384-1
  27. 10.2165/00002018-200124090-00005 · doi:10.2165/00002018-200124090-00005
  28. 10.1097/00005344-198400065-00025 · doi:10.1097/00005344-198400065-00025
  29. 10.1016/S1368-8375(98)00068-2 · doi:10.1016/s1368-8375(98)00068-2
  30. 10.1111/j.1464-410X.1995.tb07264.x · doi:10.1111/j.1464-410x.1995.tb07264.x
  31. 10.1046/j.1532-5415.2001.49144.x · doi:10.1046/j.1532-5415.2001.49144.x
  32. Mangrella M, 1998, Hospital intensive monitoring of adverse reactions of ACE inhibitors, Minerva Med, 89, 91
  33. Meaney PJ, 1997, Methadone and caries, Aust Dent J, 42, 138
  34. Nagler RM, 1998, Effects of radiotherapy and chemotherapeutic cytokines on a human salivary cell line, Anticancer Res, 18, 309
  35. 10.1038/sj.bmt.1700928 · doi:10.1038/sj.bmt.1700928
  36. 10.1016/S0003-9969(01)00008-5 · doi:10.1016/s0003-9969(01)00008-5
  37. Noguchi K, 1998, Long‐term administration study of propiverine hydrochloride (BUP‐4 tablets) in pollakiuria and urinary incontinence, Hinyokika Kiyo, 44, 687
  38. 10.3109/00016359509006003 · doi:10.3109/00016359509006003
  39. 10.1067/moe.2001.118478 · doi:10.1067/moe.2001.118478
  40. Potgieter GE, 2002, Pharmacokinetics of pipamperone from three different tablet formulations, Arzneimittelforschung, 52, 430
  41. Roger M, 1998, Value of tiapride for agitation in the elderly. Review of published studies, Encephale, 24, 462
  42. Skopouli FN, 1995, Cytokines in Sjogren's syndrome, Ann Med Interne (Paris), 146, 219
  43. 10.14219/jada.archive.1995.0277 · doi:10.14219/jada.archive.1995.0277
  44. 10.1111/j.1741-2358.1995.tb00139.x · doi:10.1111/j.1741-2358.1995.tb00139.x
  45. 10.1111/j.1752-7325.2000.tb03286.x · doi:10.1111/j.1752-7325.2000.tb03286.x
  46. 10.1046/j.1464-410x.2000.00520.x · doi:10.1046/j.1464-410x.2000.00520.x
  47. 10.1016/0140-6736(92)92791-D · doi:10.1016/0140-6736(92)92791-d
  48. Vissink A, 1992, Dry mouth; possible cause – pharmaceuticals, Ned Tijdschr Tandheelkd, 99, 103
  49. 10.1097/00002030-199715000-00022 · doi:10.1097/00002030-199715000-00022
  50. Wishart JM, 1981, Systemic treatment of psoriasis with an oral retinoic acid derivative (Ro‐10–9359), Tigason NZ Med J, 94, 307
  51. Zwieten PA, 2000, Renewed interest in centrally acting antihypertensive drugs, Cardiovasc J S Afr, 11, 225

Cited by

See all 472

Metadata

Authors
Scully CBE, C.
Venue
Oral Diseases
Publisher
Wiley
Published
2003-06-12
Volume
9
Issue
4
Pages
165-176
ISSN
  • 1354-523X (ISSN-L)
  • 1601-0825
OpenAlex
W2105382071
Cited by
472
References
99
FWCI
4.52
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug effects on salivary glands: dry mouth. https://app.cochat.ai/papers/10.1034/j.1601-0825.2003.03967.x
The paper
Scully CBE, C. (2003). Drug effects on salivary glands: dry mouth. Oral Diseases. https://doi.org/10.1034/j.1601-0825.2003.03967.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.